Conditional Deletion of the Glutamate Transporter GLT-1 Reveals That Astrocytic GLT-1 Protects against Fatal Epilepsy While Neuronal GLT-1 Contributes Significantly to Glutamate Uptake into Synaptosomes

GLT-1 (EAAT2; slcla2) is the major glutamate transporter in the brain, and is predominantly expressed in astrocytes, but at lower levels also in excitatory terminals. We generated a conditional GLT-1 knock-out mouse to uncover cell-type-specific functional roles of GLT-1. Inactivation of the GLT-1 g...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 35; no. 13; pp. 5187 - 5201
Main Authors Petr, Geraldine T, Sun, Yan, Frederick, Natalie M, Zhou, Yun, Dhamne, Sameer C, Hameed, Mustafa Q, Miranda, Clive, Bedoya, Edward A, Fischer, Kathryn D, Armsen, Wencke, Wang, Jianlin, Danbolt, Niels C, Rotenberg, Alexander, Aoki, Chiye J, Rosenberg, Paul A
Format Journal Article
LanguageEnglish
Published 01.04.2015
Online AccessGet full text

Cover

Loading…
More Information
Summary:GLT-1 (EAAT2; slcla2) is the major glutamate transporter in the brain, and is predominantly expressed in astrocytes, but at lower levels also in excitatory terminals. We generated a conditional GLT-1 knock-out mouse to uncover cell-type-specific functional roles of GLT-1. Inactivation of the GLT-1 gene was achieved in either neurons or astrocytes by expression of synapsin-Cre or inducible human GFAP-CreERT2. Elimination of GLT -1 from astrocytes resulted in loss of ~ 80% of GLT -1 protein and of glutamate uptake activity that could be solubilized and reconstituted in liposomes. This loss was accompanied by excess mortality, lower body weight, and seizures suggesting that astrocytic GLT-1 is of major importance. However, there was only a small (15%) reduction that did not reach significance of glutamate uptake into crude forebrain synaptosomes. In contrast, when GLT-1 was deleted in neurons, both the GLT-1 protein and glutamate uptake activity that could be solubilized and reconstituted in liposomes were virtually unaffected. These mice showed normal survival, weight gain, and no seizures. However, the synaptosomal glutamate uptake capacity (V sub(max)) was reduced significantly (40%). In conclusion, astrocytic GLT-1 performs critical functions required for normal weight gain, resistance to epilepsy, and survival. However, the contribution of astrocytic GLT-1 to glutamate uptake into synaptosomes is less than expected, and the contribution of neuronal GLT -1 to synaptosomal glutamate uptake is greater than expected based on their relative protein expression. These results have important implications for the interpretation of the many previous studies assessing glutamate uptake capacity by measuring synaptosomal uptake.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-2
ISSN:0270-6474
1529-2401
DOI:10.1523/JNEUR0SCI.4255-14.2015